Stock Information
Summit Therapeutics Inc (SMMT)
Ticker Symbol: SMMT
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $10,105.64 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -1.12
Revenue (TTM): $0.00 M
Dividend Yield: N/A
ROE: -168.93%
Latest News
-
Summit Therapeutics: Signals Of Moving Past Lung Cancer (Rating Upgrade)
Wed, Aug 26, 2026 4:43 PM
-
Summit Therapeutics Partner Highlights Positive Interim Data Milestone for Lead Cancer Therapy
Wed, Aug 26, 2026 1:46 PM
-
Nasdaq 100 Falls as Hot PCE Inflation Stirs Rate-Hike Bets: Stock Market Today
Wed, Aug 26, 2026 12:58 PM
-
Abercrombie & Fitch Posts Upbeat Q2 Results, Joins Semtech, Summit Therapeutics And Other Big Stocks Moving Higher On Wednesday
Wed, Aug 26, 2026 10:16 AM
-
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Wed, Aug 26, 2026 8:06 AM
-
HC Wainwright & Co. Reiterates Neutral on Summit Therapeuticsto Neutral
Wed, Aug 26, 2026 6:55 AM
Key Financials
Financial data not available
